SPRAVATO® (Esketamine) for Treatment-Resistant Depression

by Marpa Minds

Treatment-resistant depression can make everyday life feel overwhelming, especially when traditional antidepressants have not provided meaningful relief. This video explains how SPRAVATO® (esketamine) is used for eligible adults with treatment-resistant depression, what makes it different from conventional antidepressants, and what patients can expect during treatment. Created by Marpa Minds, this educational video helps patients and families better understand evidence-based treatment options for depression and when it may be appropriate to speak with a qualified mental health professional.